Androgenetic Alopecia or hereditary hair loss, considered by many as an outward and undesirable sign of premature aging that can be ‘seen from across the room,’ currently affects an estimated 50 Million men and 30 Million women in the U.S. Approximately 40% of men in their 40’s are experiencing hair loss and 50% of men in their 50’s with over a billion dollars spent in the U.S. annually on medical treatments, hair transplants, non-medical ‘cures’ and cover-ups to address the condition.
Hormone replacement therapy (HRT) that includes androgens/testosterone may accelerate the progression of unwanted androgenetic alopecia, especially in those patients whose hair follicles are highly androgen sensitive.
OBJECTIVE: Patients who undergo testosterone replacement may be at risk for hair loss related side effects. It is our goal to present an overview of the mechanisms of Androgenetic Alopecia, new diagnostic and monitoring methods, prevention/treatments options and management stratagems specifically for patients who are undergoing an Hormone replacement therapy regimen that includes testosterone.
Chief Complaint & Goals
Lab Testing / Measurements
Cross Sectional Bundle Trichometry Measurements with Hair Check(TM)
Standardized Global Photos
Scalp Microscopic Photos
Recommended Tracking & Follow-Up Schedule
Identifying patients at risk for hereditary hair loss as well as being able to offer guidance and treatment options holds significant benefit for the Age Management (Anti-Aging) Physician and their Hormone Replacement patients because it:
1) enhances the risk/benefit discussion with the testosterone patient.
2) Identifies and addresses a possible side-effect and potential barrier to HRT compliance.
3) Adds a beneficial service to the Age Management Physician’s repertoire that may enhance patient retention and compliance.
4) Successful hair loss management adds a psychological boost to a Androgen Replacement patient’s outlook.